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Pathophysiology of proteinuria. Proteinuria is consequence of and sterical configuration. Large and negatively charged
two mechanisms: the abnormal transglomerular passage of pro- molecules are less readily filtered than small and electro-
teins due to increased permeability of glomerular capillary wall neutral or positively charged ones. The mechanismsand their subsequent impaired reabsorption by the epithelial
whereby normal glomerular capillary wall restricts thecells of the proximal tubuli. In the various glomerular diseases,
transmural passage of large plasma proteins have beenthe severity of disruption of the structural integrity of the
glomerular capillary wall correlates with the area of the glomer- extensively explored in the last 25 years, but a universally
ular barrier being permeated by “large” pores, permitting the accepted theory has not yet been agreed upon. There is
passage in the tubular lumen of high-molecular-weight (HMW) a consensus that the glomerular wall may be thought ofproteins, to which the barrier is normally impermeable. The
as containing three barriers in series. Along its route toincreased load of such proteins in the tubular lumen leads to
this filtration barrier, the filtrate first has to pass throughthe saturation of the reabsorptive mechanism by the tubular
cells, and, in the most severe or chronic conditions, to their the open pores of the glomerular endothelium, then
toxic damage, that favors the increased urinary excretion of through the highly hydrated collagenous network of the
all proteins, including low-molecular-weight (LMW) proteins, glomerular basement membrane (a molecular scaffoldwhich are completely reabsorbed in physiologic conditions.
composed of tightly cross-linked type IV collagen, lami-Recent clinical studies showed that in patients with glomeru-
nin, nidogen, and proteoglycans), and finally, through thelar diseases the urinary excretion of some HMW proteins [im-
munoglobulins G and M (IgG and IgM)] and of some LMW filtration slits established by interdigitations of podocyte
proteins, 1-microglobulin, 2-microglobulin, correlates with the foot processes and covered by a complex structure called
severity of the histologic lesions, and may predict, better than “slit diaphragm,” which is anchored at the sides of thethe quantity of proteinuria, the natural course, the outcome,
adjacent foot processes [1–6]. Although the fenestratedand the response to treatment. It is suggested that some patients
endothelium can represent an electrostatic barrier forhave already, at the time of clinical presentation, a structural
damage of the glomerular capillary wall (injury of podocytes) negatively charged proteins, and glomerular basement
and of the tubulointerstitium, the severity and scarce reversibil- membrane with its laminae can restrict the traversal of
ity of which are reliably indicated by an elevated urinary excre- large plasma proteins and negatively-charged proteinstion of HMW and LMW proteins.
(due to the presence of heparan sulfate proteoglycans),
recent evidence suggests that the ultimate, more selective
PHYSIOLOGIC MECHANISMS OF barrier for the majority of proteins resides in the slit
GLOMERULAR FILTRATION AND TUBULAR diaphram [7–9]. However, the molecular composition of
REABSORPTION OF PROTEINS this last structure is still largely unknown. The most re-
cent studies tend to confirm the model of substructureDeterminants of the transglomerular passage of
proposed by Rodewald and Karnovsky [10] in 1974 onplasma proteins
the basis of their transmission electron microscopic find-Despite the extremely low resistance to water flow, the
ings, according to which the slit diaphram is made up ofglomerular capillary wall very efficiently restricts the pas-
rod-like units connected in the center to a linear bar,sage of proteins from the blood into Bowman’s space
forming a zipper-like pattern. Nephrin, a molecule spe-on the basis of their molecular size, electrical charge,
cifically expressed in podocytes, has been suggested by
Tryggvason [8] to be the candidate molecule that might
assemble into a zipper-like isoporous filter structure.Key words: proteinuria, glomerular wall permselectivity, urinary IgG,
urinary 1-microglobulin, podocytes. Nephrin molecules extending toward each other from
two adjacent foot processes are likely to interact in the
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in the slit diaphragm and could be involved in the struc-
ture of the adherent junctions of a zipper-like filter [9].
Very recently, two other proteins have been discovered
as components of the slit diaphragm domain of podocytes,
CD2AP, which for its structure probably acts as an adap-
tor linking the actin-based cytoskeleton of podocyte to
nephrin [12], and podocin, a stomatin-like protein that
forms aggregates and organizes lipid rafts [13]. A complex
of nephrin, podocin, and CD2AP is emerging as the
functional unit upon which the slit diaphragm assembles.
These proteins are tightly associated and are embedded
into lipid rafts. Podocin may be critical for the stability
of this complex; its binding dramatically activates the
signaling capabilities of nephrin [13–16]. The basal por-
tion of podocytes is attached to the glomerular basement
membrane through several adhesion proteins. The integ-
rin 31 and the dystoglycan complex are the major re-
sponsable for the binding to the extracellular matrix of
such basement membrane [14–16]. 31 integrin con-
stitutes stable, static bonds, and is associated on its
cytoplasmic side with paxillin, talin, and vinculin, which
mediate its connections to the actin cytoskeleton. The
dystoglycan complex probably provides an actin-directed
positioning system by which podocytes activity control
the exact spacing of matrix proteins, and thus the poros-
ity and permeability of the glomerular basement mem-
brane [15].
In the last 20 years, numerous studies have been per-
Fig. 1. Glomerular pore size distribution in normal individuals (solidformed, in experimental animals and in humans, based
curves) and in nephrotic patients (dashed curves), according to the twoon the measurement of the fractional excretion (sieving most accepted theoretical models. (A ) The membrane is perforated by
coefficient) of some biologically inert molecules of differ- a single population of cylindrical restrictive pores that have a continuous
log-normal distribution of radii (heteroporous model). (B ) The mem-ent size, either neutral or charged, used as test transport
brane is perforated by a lower distribution of restrictive pores with a
probes. They demonstrated that glomerular capillary log-normal distribution of radii and a parallel upper distribution of
nonrestrictive dimensionless shunt-like pores (bimodal heteroporouswall, as a whole, can be assumed to be perforated by
shunt model).cylindrical pores of different diameter. The most used
have been for years the dextrans of different size. They
have given useful results for the definition of the porosity
of the glomerular filter. However, like many of the pro- with a log-normal distribution of radii extending to radii
teins physiologically crossing this filter, they are de-
60 A˚ (Fig. 1A) has been recently considered the best
formable and flexible (differences in molecular configu-
fitting model by Ruggenenti et al [28]. In contrast, othersration may have an important influence on the relative
[18, 20, 24, 27], using as transport probe not only dex-filtration rates of proteins); therefore, they did not allow
trans, but also Ficoll, have recently concluded that ato precisely define the real radius of the pores. More
bimodal model better fits the description of their resultsrecently, another inert molecule, Ficoll, has been pre-
(Fig. 1B). They hypothesized a prevailing population offerred for such studies, because it is a rigid spherical
small restrictive pores with a log-normal distribution ofmolecule, the configuration of which is not altered during
radii, with a mean radius around 45 A˚, with a rangetransglomerular passage. Many different mathematical
between 37 and 48 A˚, and a limited number of nonrestric-models, based on hemodynamic theories, have been pro-
tive pores (80 A˚), that they called the “shunt” pathway,posed in order to explain the results of the studies on the
that in physiologic conditions is permeated by a verytransport probes. The models most extensively accepted,
small fraction of filtrate (only 0.1  103 on average).called heteroporous models, consider the glomerular
However, even among the supporters of the bimodalcapillary wall as a membrane perforated by pores of
distribution, not everyone accepts the nonrestrictive na-different diameter having a log-normal distribution of
radii [17–29]. A single population of restrictive pores ture of the large shunt-like pores. A group of investiga-
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tors from Lund [25, 26, 29], using a different approach Renal tubular handling of filtered proteins
to the study of glomerular permeability based on the As we have stated, in normal conditions only a fraction
inhibition of tubular reabsorption in animal models, of proteins of intermediate molecular weight, in particu-
agrees on the existence of two populations of pores, the lar albumin, the concentration of which in the Bowman’s
vast majority being “small pores,” but hypothesizes that space of healthy animals has been calculated to be ap-
even the second pore population consists of a limited proximately 1 mg/dL [30, 31] or even higher [32], and
number of discriminatory “large pores” with a radius 80 almost none of the high-molecular-weight (HMW) pro-
to 90 A˚. These investigators postulate that, in addition tiens arrives in the tubular lumen. On the contrary, the
to the two populations of pores, sporadic “membrane passage across the glomerular filter of all proteins of
defects” or “shunts” large enough to allow transport of molecular weight lower than 40,000 D and radius lower
very large proteins of the size of 2-macroglobulin and than 30 A˚, the so-called low-molecular-weight (LMW)
even red blood cells (similar to the non-discriminating proteins, is almost completely unrestricted in the normal
shunt-like pores proposed by the Myers group) could individuals. All these proteins that arrive in the tubular
also exist, and that they should contribute less than 105 lumen are excreted in negligible amounts in the urines
of the total glomerular filtration rate (GFR) in physio- in physiologic conditions because of a very efficient
logic conditions, but could increase in number in patho- mechanism of total reabsorption by the epithelial cells
logic conditions (“two pores with a shunt” model). of proximal tubules (Fig. 2A). For 2-microglobulin, the
It is accepted by all investigators that in physiologic molecular radius of which is 11.8 A˚, the block of tubular
conditions, proteins of the size of immunoglobulin G reabsorption with lysine in normal rats increased the
(IgG) (molecular radius  55 A˚) are completely (or clearance by a factor of 450, while the clearance of large
almost completely) restricted from filtration because proteins increased only five- to sixfold [20].
their radius is higher than that of all the small restrictive This reabsorption of proteins occurs predominantly in
pores, and the contribution of the shunt pores or large the pars convoluta (S1 and S2 segments) and, to a lesser
selective pores is quantitatively irrelevant (Fig. 2A). On extent, in the pars recta (late S2 and S3 segments) of the
the contrary, the low permeability of the glomerular proximal tubule. The epithelial cells of these segments
capillary wall to albumin (molecular radius  36 A˚) contain an extensive apical endocytic apparatus, con-
cannot be explained in terms of simple restriction by pore sisting of a network of coated pits and small coated
size. The majority of investigators refer the restricted and noncoated endosomes, but also of prelysosomes,
movement of this protein to the Bowman’s space to some lysosomes, and so-called dense apical tubules involved
characteristics related to its negative charge and to the in recycling membrane from the endosomes to the apical
consequent electrostatic repulsive interactions with the plasma membrane. The proteins absorbed at the luminal
negative charge of the glomerular capillary wall. It has membrane are endocytosed and concentrated within ves-
been demonstrated experimentally that some transport icles at the apical border of tubular cells (endocytic vesi-
probes, if negatively charged, cross the glomerular filter cles). These vesicles fuse with acidic organelles that be-
with a reduced sieving coefficient and that neutralization long to the endosomal compartment. The endosomes
of the anionic sites of glomerular basement membrane containing the segregated proteins then migrate to the
by polycations results in increased permeability to such cell interior, where they fuse with the lysosomes, cell
probes, as well as to albumin. It has been recently calcu- organelles that contain acid hydrolases. Absorbed pro-
lated, using uncharged Ficoll as a probe, that, in rats, teins are completely hydrolyzed within lysosomes and
albumin has a much lower sieving coefficient compared the resulting aminoacids cross the contraluminal mem-
with Ficoll of the equivalent size of 36 A˚ [28] and that brane to return to the circulation [33, 34].
in normal individuals albumin filtration is restricted by Until recently, it was believed that proteins were
a factor of approximately 100 relative to a 36 A˚ probe largely absorbed by nonspecific absorbptive endocytosis,
[24]. However, the role of charge selectivity in permselec- the tubular uptake being a high-capacity, low-affinity
tivity of glomerular capillary wall has been recently ques- transport system. However, kinetic parameters differ sig-
tioned [22]. The anionic charge of the capillary wall has nificantly according to the charge of proteins, and, even
been estimated to be much lower than that required to for proteins of similar size and net charge, there is com-
affect the clearance of some proteins based on charge petition for tubular absorption among the various pro-
repulsion. Even the higher fractional clearance of cat- teins. Moreover, in the case of albumin, in addition to the
ionized dextran in comparison with its anionic counter- high-capacity, low-affinity transport system, which is uni-
part found in many in vivo experiments has been ex- versal among all proteins tested, a low-capacity transport
plained arguing that this cationic polysaccharide binds system has been found that is probably operational in
to anionic sites and damages the glomerular capillary the lower ranges of tubular fluid albumin concentration
[35–37]. There is a growing body of evidence suggestingwall, making it leaking [22].
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Fig. 2. Schematic representation of transglo-
merular transfer to the tubular lumen, reabsorp-
tion by the tubular cells and excretion in the
urines of plasma proteins of low-molecular-
weight (LMW), intermediate-molecular-weight
[mainly albumin ALB)], and high-molecular-
weight (HMW) in physiologic conditions and
in pathologic conditions characterized by pro-
gressively increasing permeability of the glo-
merular barrier and reabsorptive load of the
tubular cells. (A ) In physiologic conditions,
all LMW proteins and a fraction of albumin
cross the glomerular barrier and are com-
pletely reabsorbed by the tubular cells. (B )
The alteration of the permeability of the glo-
merular barrier is moderate, involving mainly
a loss of restriction to passage of negatively
charged proteins (especially albumin); albu-
min and a small fraction of HMW proteins
reach the tubular lumen and saturate the re-
absorptive capacity of tubular cells, inducing
the loss in the urines of a fraction of LMW
proteins and albumin, together with a very
small fraction of HMW proteins (selective
proteinuria).
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Fig. 2. (Continued) (C ) A more severe dam-
age progressively increases size permeability
of the glomerular barrier, and, due to the satu-
ration of the reabsorptive mechanisms of tu-
bular cells, a greater percentage of HMW pro-
teins is excreted in the urines (nonselective
proteinuria). (D ) Permeability of the glomer-
ular barrier is further increased, and the mas-
sive and protracted reabsorptive load of the
tubular cells induces toxic lesions of these cells
and reduces their reabsorptive capacity; excre-
tion with the urines of all three classes of pro-
teins and, in particular, of LMW and HMW
proteins, is increased, and represents a valid
marker of the severity of the glomerular and
tubular damage.
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that the absorption of albumin, as well as all other pro- the experimental studies using inert test probes, reported
above, showed that the alteration of the selectivity ofteins, through the entire length of the proximal tubule
but especially in its pars convoluta, is “receptor-medi- the glomerular capillary wall was a combination of the
loss of charge restriction and size restriction. These stud-ated” as opposed to “nonspecific.” It is assumed that
the luminal endocytosis is initiated by ligand binding to ies did not necessarily show an increase in the mean
radius of the small restrictive pore population, but rather,receptors localized in the clathrin-coated pits, followed
by internalization, segregation of ligands and receptors in all experiments, demonstrated a spread of their distri-
bution due to the appearance of more and wider large-in early and late endosomes, and directing of ligands
to lysosomes for degradation, while the receptors are pore pathways (either discriminatory or shunt-like pores)
(Fig. 1). According to Tencer et al [42], even for the largedirected back to the apical plasma membrane via dense
apical tubules [34]. Data gathered in recent years indicate pores, a charge restriction exists in physiologic conditions,
and explains why, especially in membranous nephropa-that megalin and cubilin play a crucial role in this process
[38]. Both are multiligand receptors massively expressed thy, the ratio between urinary concentration of neutral
IgG2 and negatively charged IgG4 is significantly re-in the proximal tubules (but also in several other epithe-
lia). Although they belong to distinct protein families, duced, indicating a loss of the charge restriction for IgG4.
The reduction in the restrictive properties of the glo-they share a common structural feature, the accumula-
tion of motifs potentially important for ligand binding, merular barrier leads to proportionally greater increases
in the filtered loads of albumin and HMW proteins thanwhich confers upon them a key property for multiligand
receptors. Both are detectable over the apical endocytic of LWM proteins; the glomerular permeability of the
latter is already very high and cannot increase further,apparatus: clathrin-coated pits, small and large endo-
somes, and dense apical tubules. Megalin and cubilin whereas even a small increase in glomerular permeability
to macromolecules leads to very significant increases inappear to carry on a cooperative function, clearly demon-
strated in the case of the absorption of albumin, where the filtered load of larger proteins.
this apparently redundant interaction results in a very
Increased transglomerular passage and urinaryefficient uptake, even though in the case of transferrin,
excretion of intermediate and HMW proteinscubilin appears to be exclusively involved in the internal-
A moderate increase in the permeability of the glo-ization process. Megalin and cubilin, although putative
merular capillary wall is characteristically found in mini-receptors, do not appear to be very selective, as many
mal change nephropathy and in some initial stages ofproteins are able to bind to them. Because of this multi-
other glomerular diseases (primary focal segmental glo-plicity of ligands, it would probably be more appropriate
merulosclerosis, membranous nephropathy, diabetic ne-to characterize them as “binding proteins” rather than
phropathy). The increased transglomerular passage inas “receptors” [34]. A potential role of megalin to signal
the tubular lumen of intermediate-molecular-weight pro-into the cell interior to stimulate cell proliferation has
teins, mainly albumin, is not accompained by a similarbeen very recently hypothesized [39].
passage of HMW proteins, such as IgG,2-macroglobulinIt is worth stressing that cationic proteins, such as
or IgM. Despite their partial reabsorption by the tubularIgG, have been shown to bind more avidly to the apical
cells, a fraction of albumin and intermediate-molecular-membrane of proximal tubule cells because such mem-
weight proteins escapes the reabsorptive process andbrane is negatively charged. As a consequence, cationic
appears in the urine. The ensuing proteinuria is indicatedproteins present in the tubular lumen are more readily
as “selective” (Fig. 2B). A selectivity index (SI) basedendocytosed than anionic proteins such as albumin
on the comparison of the clearance of IgG, as a marker[40, 41]. This competitive mechanism adds another vari-
of proteins of HMW, and that of transferrin, as a markerable that affects the concentration of filtered proteins in
of proteins of intermediate size, had already been elabo-the final urine, and renders the correct calculation of the
rated in 1964, and since then patients with an IgG SI ofrelative sieving coefficient of HMW and LMW proteins
0.2 or higher have been considered to have a nonselectiveand of the selectivity index more difficult, especially in
proteinuria, whereas patients with a ratio below 0.2 havepathologic conditions.
been considered to have a selective proteinuria [43]. In
spite of the criticism to the theory of charge restriction,
PATHOPHYSIOLOGY OF ABNORMAL to which we alluded in a previous section, the majority
URINARY PROTEIN EXCRETION IN of investigators still believe that in these pathologic con-
GLOMERULAR DISEASES ditions characterized by selective proteinuria, the impair-
Increases in the urinary excretion of proteins result ment of the charge selectivity of the glomerular filter is
from increases in their filtered load, due to alterations prevalent in comparison with the impairment of size.
in the permselectivity of the glomerular capillary wall, The injury to the structures of the glomerular capillary
wall impairs their function as a negatively charged elec-or from defects in their tubular uptake. The majority of
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trostatic barrier, permitting the unrestricted transglo- thy and control groups, the authors suggested that “mas-
sive immunoglobinuria is attributable to an impairmentmerular passage of albumin, while the damage respons-
able for the increase of the large nonselective pores of barrier size selectivity, whereas the massive albumin-
uria is due to a defect of charge selectivity” [24]. In patientspermeating the capillary wall is less marked. A loss of
anionic sites of the glomerular basement membrane has with IgA nephropathy [51], whose proteinuria was less
severe than that of patients with membranous nephropa-been documented in minimal change nephropathy [44, 45]
and in the microalbuminuric stage of diabetic nephropa- thy, the study with Ficoll confirmed that the fraction of
filtrate permeating the large shunt-like pores was signifi-thy [46]. In both conditions the study with dextrans has
confirmed a very mild increase of the area of the glomer- cantly increased in comparison with non-proteinuric con-
trols. At variance with the results obtained in nephroticular filter being permeated by large pores, while the
transglomerular passage of albumin through the small patients with membranous nephropathy, no differences
from control subjects were found in the mean radius ofselective pores is more markedly increased [18, 47–49].
In all the glomerular diseases with nonselective protein- the small restrictive pores or the range of distribution
of these pores. There was a significant relationship be-uria, the variable quantity of proteins of HMW reaching
the tubular lumen is an expression of a variable severity tween the fractional clearance of albumin and IgG and
the fraction of filtrate passing through large shunt-likeof the impairment of the size selectivity, in addition to
that of the charge selectivity (Fig. 2 C and D). The sieving pores in this population of patients [51].
Similar studies [28, 29, 47–49, 52, 53] using neutralcoefficient of large (60 A˚) dextrans has been found
to be more increased in patients with focal segmental dextrans or Ficoll as probes have been carried out in the
various stages of type 1 or type 2 diabetic nephropathy.glomerulosclerosis, in comparison with patients with
minimal-change nephropathy, in the study already men- These studies showed that the evolution of the disease,
through the microalbuminuric stage, to one of overt pro-tioned [18]. Another study of the same group [50], com-
paring the sieving coefficients of uncharged dextran and teinuria, represents a continuum of progressively de-
ranged glomerular capillary wall function. As we said,anionic dextran sulfate in nonproteinuric controls and
in two groups of nephrotic patients, with minimal-change in the microalbuminuric stage all parameters of size se-
lectivity (mean radius and spread of radius distributionnephropathy and membranous nephropathy, confirmed
that the permeability to large uncharged dextrans, pres- of restrictive pores, as well as the magnitude of the large
pores) were unaltered or moderately altered. With in-ent in all nephrotic patients, was more evident in patients
with membranous nephropathy. The sieving coefficient creasing severity of the nephropathy, in the stage of overt
proteinuria, the number and peak radius of the restrictiveof the anionic dextran sulfate of small radius (18 A˚)
was definitely lower than that of uncharged dextrans small pores was still unaltered or moderately increased.
The increased filtration of IgG and other proteins ofof similar radius in nonproteinuric controls, but not in
nephrotic patients, indicating a loss of charge restriction HMW could be explained with an increased fraction of
filtrate being permeated by large pores. In type 2 diabeteswhich could explain the magnitude of albuminuria better
than the concomitant increase in filtration of large neu- of Pima Indians, it was calculated, using dextrans as
probes, that an excess of large pores becomes evidenttral dextrans.
More recent studies of the same investigators from when albuminuria reaches a level of 3 grams per gram
of creatinine [49]. In the same disease in Italian patients,Stanford, using Ficoll test probe, have been performed
in membranous nephropathy [24] and IgA nephropathy using the same probes, Ruggenenti et al [28] concluded
that distribution of pore sizes was on average shifted[51]. In comparison with dextrans, sieving coefficients
for all restricted Ficoll molecules (probably because their toward larger pores, as compared to normal controls,
the mean pore size radius being of 5 A˚ greater (Fig. 1A).conformation was not altered during transglomerular
permeation) were uniformly lower than those of dex- The majority of investigators agreed that, when overt
proteinuria develops in the nephropathy of both typestrans in nonproteinuric controls [24]. In patients with
membranous nephropathy, the membrane parameters of diabetes, concomitant changes of charge—and size—
selectivity are likely to contribute to albuminuria. How-measured with Ficoll differed from control in two re-
spects: (1) the distribution of restrictive pores was broad- ever, Bakoush et al [29] found a better preserved ratio
of IgG2/IgG4 urinary excretion in European patientsened, the mean radius (36 A˚) being shifted to smaller
size (from 44 A˚ to 36 A˚); (2) the magnitude of the area with type 2 diabetes than in those with type 1 diabetes
and argued that in the former group charge selectivitybeing permeated by large shunt-like pores was substan-
tially increased, the sieving coefficient for Ficoll of equiv- is less impaired even in the macroalbuminuric stage.
They suggested that in type 2 diabetes even albumin isalent radius to IgG (54-56 A˚) being enhanced above
control by a factor of 20. Since the sieving coefficient lost primarily through the large pore pathway. According
to these investigators, even urinary excretion of IgM, aof Ficoll of equivalent radius to albumin (36 A˚) did not
differ between the patients with membranous nephropa- protein of molecular weight and radius higher than IgG,
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was more frequently detectable in type 2 than in type 1 clearance of albumin and IgG was significantly corre-
lated with the percentage of glomerular basement mem-diabetes; this difference was explained as reflecting a
more marked increase in the population of the nonselec- brane occupied by dense deposits, by the slit number/
glomerular basement membrane surface and by the thick-tive shunt-like pores in type 2 diabetes.
Structural-functional correlations have been analyzed ness of glomerular basement membrane [62]. Finally, in
all human glomerular diseases, when the injury to thein both diabetic and nondiabetic nephropathies associ-
ated with documented changes in size selectivity. glomerular capillary wall was severe, morphologic de-
fects of glomerular basement membrane have been de-In overt diabetic nephropathy of Pima Indians, Lemley
et al [49] documented increased glomerular basement scribed, such as tunnels [63, 64] or focal areas of rupture
or holes in the wall [65, 66]. They are probably responsi-membrane thickness, greater foot process width, and a
decreased number of visceral epithelial cells per glomer- ble for the leakage of very large proteins (“shunt path-
way”) and might allow the passage of blood cells.ulus; at multivariate regression analysis, only foot pro-
cess width was significantly correlated with the increase It must be stressed that not only structural lesions, but
also glomerular hemodynamic changes, affect the perme-in larger size pores.
In nondiabetic glomerular diseases characterized by ability of glomerular capillary wall to macromolecules.
Filtration of proteins is influenced not only by the intrin-prevalent lesions of the glomerular capillary wall, like
membranous nephropathy and focal segmental glomeru- sic membrane properties of the glomerular capillary wall,
but also by the other determinants of single-nephronlosclerosis, the changes in charge and size selectivity have
been ascribed to alterations of foot processes and slit GFR: the glomerular capillary plasma flow rate (QA), the
glomerular transcapillary hydraulic pressure differencemembranes of epithelial cells, especially when efface-
ment of adjacent foot processes or complete detachment (P), and the afferent arteriolar plasma protein concen-
tration (CA). Moreover, it is becoming increasingly ap-of some foot processes and their slit membranes from
the lamina rara externa of the basement membrane are parent that hemodynamic alterations, either of pressure
or flow, may directly influence the permeability proper-detected [27, 54, 55], but also to the alterations of the
structural modeling of the glomerular basement mem- ties of the barrier itself, as reflected by changes in the
apparent pore size distribution and/or the concentrationbrane [56, 57]. We have already mentioned the loss of
anionic sites from such basement membrane and from of fixed negative charges on the membrane [67].
The studies in normal rats [67–69], even after infusionpodocytes, responsible for charge selectivity in some pro-
teinuric diseases. Decreased density of slit processes of of angiotensin II [70–75], or stimulation of endogenous
angiotensin by renal vein constriction [76], have permit-glomerular epithelial cells has been also documented
morphometrically in human disease with nephrotic syn- ted better characterization of the effect of hemodynamic
changes. It has been found that (1) selective increase indrome [52], probably favored by the limited capacity
of mature glomerular epithelial cells to proliferate [58]. glomerular plasma flow rate (QA), up to a certain level,
tends to decrease the fractional clearance of macromole-Dedifferentation of glomerular epithelial cells in some
proteinuric diseases, especially focal segmental glomeru- cules (an effect due to a disproportionately greater in-
crease in the average transcapillary volume flux thanlosclerosis, is suggested by the decreased expression of
surface antigens usually present in mature cells [59, 60]. solute flux), while a decline in QA has the opposite effect;
(2) selective increase of transcapillary hydraulic pressureIn glomerular diseases with mesangial involvement, such
as IgA nephropathy, data are more controversial. Ike- gradients (P) leads to a decrease of the fractional clear-
ance of macromolecules, even through it induces an in-gaya et al [61] found that the increase in pore size corre-
lated with mesangial sclerosis and tubulointerstitial dam- crease in diffusion-driven macromolecule flux because it
leads to an even greater increase in water flux; however,age, more than with the severity of capillary changes.
On the contrary, in their very accurate study, already when P increases markedly, in response to a decline
in plasma flow rate (QA), to maintain a normal single-quoted, Lemley et al [51] have found that a reduced
number of podocytes/glomerulus was the most signifi- nephron GFR, the consequent increase in filtration frac-
tion induces an increase in the fractional clearance ofcant morphometric feature associated with other mark-
ers of increasing disease severity such as loss of size proteins; (3) intravenous infusion of angiotensin II leads
to proteinuria, concomitant and partially related to hemo-selectivity of the glomerular barrier, IgG urinary frac-
tional excretion, extent of glomerular sclerosis and de- dynamic changes characterized by a significant decrease
in QA and by a rise in P, with significant rise in filtrationcrease of GFR; they suggested that, whereas IgA ne-
phropathy is initiated by intramesangial deposition of fraction; the degree of proteinuria is strictly correlated
with the changes of QA and filtration fraction; (4) stimu-IgA, it is the injury to, and loss of, podocytes from the
outer aspect of the glomerular basement membrane that lation of intrinsic angiotensin with renal vein constriction
produces similar hemodynamic changes and proteinuria,determines the severity of disease as well as its rate of
progression. In a model of lupus nephritis, the fractional due mainly to increased efferent arteriolar resistance,
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P, and filtration fraction; (5) infusion of angiotensin crease in the fraction of filtrate being permeated by large
II or stimulation of intrinsic angiotensin II markedly shunt-like pores [52, 53, 58, 80, 82, 83, 88, 90, 95], and
increase the fraction of filtrate passing through larger, therefore reduce the fractional clearance of HMW pro-
nonselective pores; thus, changes inP play an important teins, such as IgG. The same reduction in the clearance
role in glomerular permselectivity since on increase in of large dextrans, with parallel reduction of the fractional
P recruits previously unexposed large pores of the non- clearance of IgG, has been found recently in diabetic
selective shunt pathway; and (6) saralasin, an inhibitor nephropathy after 6 months to 1 year of administration
of angiotensin, counteracted the effects of angiotensin of the nondihydropiridine calcium channel blocker, dilti-
II stimulation by renal vein constriction, induced reduc- azem, but not of nifedipine. Only diltiazem induced a
tion of efferent arteriolar resistance and P almost to significant immediate reduction of proteinuria that could
preconstriction levels, normalized filtration fraction, de- not be explained as due to changes in intrarenal hemody-
creased proteinuria, and corrected the barrier size per- namic different from those induced by nifedipine [98].
meability changes described above [76]. In the case of RAS inhibitors in general, an effect
When angiotensin-converting enzyme (ACE) inhibi- on partially reversible alterations in the structure and
tors, and, more recently, angiotensin I (AT1) receptor function of the glomerular capillary wall and of mesan-
antagonists became available as antihypertensive agents, gial cells and matrix, induced by intrarenal angiotensin
and their antiproteinuric properties were confirmed in II, has been hypothesized: rearrangement of junctional
many experimental models of renal disease [77–83] and complex of podocyte filtration slits, due to actin polymer-
in all human glomerular diseases [52, 53, 58, 84–91], it ization in the cytoskeleton of podocytes [95, 99]; reduc-
was initially hypothesized that their effect on glomerular tion of the increase in the level of glomerular protein
capillary wall permeability was due to the correction and cortical mRNA for transforming growth factor-
of the arterial hypertension and of the intraglomerular (TGF-), and collagen types I and III [81]; and blunting
hemodynamic changes induced by the activation of the of the marked increase in cell size of cultured cells ex-
renin-angiotensin system (RAS) that we have summa- posed to angiotensin II [100]. The fact that the antipro-
rized. However, correction of arterial hypertension using teinuric effect of angiotensin inhibitors may persist for
any other conventional antihypertensive drug does not some time after withdrawal of treatment [90] speaks in
influence the extent of proteinuria, the only exception favor of a slowly developing improvement of structural
being the nondihydropiridine calcium channel blockers, alterations. In the case of nondihydropiridine calcium
verapamil and diltiazem [92–94]. Moreover, it is becom- channel blockers, an effect on the metabolism of mesan-
ing evident that even the correction of the intrarenal gial cells [101, 102] and, in diabetic animals, an attenu-
hemodynamic alterations existing in proteinuric renal
ated decrease in both glucosaminoglycan and heparan
diseases does not fully explain the antiproteinuric effect
sulfate of the glomerular capillary wall and mesangialof angiotensin inhibitors and nondihydropiridine calcium
cells [103], have been described.channel blockers. ACE inhibitors or AT1 receptor antago-
nists exert their effect in animal models of nephritis de- Renal tubular handling of an abnormal load
spite unchanged intraglomerular pressure [79], or in ex- of filtered proteins
perimental nephritis characterized by a normal capillary
In physiologic conditions, HMW proteins are re-hydraulic pressure [80]. The long-term effect of ACE inhi-
stricted almost completely from reaching the tubular lu-bition on proteinuria in human glomerulonephritis could
men because of the impermeability of the glomerularnot be acutely reversed by intravenous administration of
barrier (Fig. 2A). More controversial is the behavior ofangiotenin II, despite a dose-related fall in renal plasma
albumin. Everyone agrees that part of it crosses the bar-flow and rise in systemic blood pressure, renal vascular
rier and arrives to the Bowman’s space, where its concen-resistance, and filtration fraction [91]. An AT1 receptor
tration is at least 1 mg/dL [30, 31]; however, recent stud-antagonist could prevent the alteration in permselectivity
ies suggest that the filtration of albumin is very partiallyof the glomerular barrier induced by exogenous angio-
restricted by charge and its concentration in the tubulartensin II even in an isolated perfused rat kidney prepara-
lumen is even higher [32]. Finally, it is universally ac-tion in which hemodynamic modification had been mini-
cepted that the passage in the tubular lumen of the pro-mized [95] As for calcium channel blockers, it is well
teins of molecular weight lower than 40 kD and radiusestablished that they do not have a stable effect on effer-
lower than 30 A˚, the so-called LMW proteins, is com-ent arteriolar tone and induce only little change in intra-
pletely unrestricted in physiologic conditions.glomerular pressure and filtration fraction [93, 96, 97].
When impairment of charge and size selectivity of theACE inhibitors and AT1 receptor antagonists seem
glomerular capillary wall increases the filtration of theto act directly on the permselectivity properties of the
proteins of intermediate and HMW, these proteins com-glomerular barrier. These drugs not only reduce the total
amount of proteinuria, but can partially correct the in- pete among themselves, and with the LMW proteins, in
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the process of reabsorption by the epithelial cells of the ment of the tubular cells in the reabsorptive mechanisms
of the proteins reaching the tubular lumen can explainproximal tubule. If this mechanism is saturated, some of
the filtered proteins of all sizes, including those of LMW, the injury of these cells and, therefore, the correlation
of the overall tubulointerstitial damage with the severityappear in the urine (Fig. 2 B to D). Unfortunately, the
fraction of the different proteins that escapes reabsorp- and duration of proteinuria.
These pathophysiologic mechanisms can also explaintion is not proportional to the filtered fraction, since it
is becoming evident that the reabsorption process is not the recent finding that some qualitative characteristics
of proteinuria are better predictors of the progressionaspecific and unselective, and that even the charge of
the various proteins influences such processes, IgG being to chronic renal failure than its quantity.
more easily reabsorbed than albumin because of its posi-
Predictive value of selectivity of proteinuria andtive charge.
urinary excretion of HMW proteinsWhen the load of filtered proteins escaping the glo-
merular barrier is massive and/or protracted, due to The assessment of SI, based on the comparison of the
clearance of IgG and transferrin, has found little placechronic glomerular injury, the epithelial cells of the prox-
imal tubule, subjected to a continuous overload, may in clinical practice for many decades, since it did not
appear to help in predicting histologic diagnosis or inprogressively lose their integrity, with impairment of ly-
sosomal function and morphologic changes (enlarge- determining prognosis, the only exception being the dif-
ferential diagnosis between minimal change nephropathy,ment of the protein absorption droplets and loss of brush-
border structure). As a result, the reabsorption of all in which proteinuria is always selective, and focal segmen-
tal glomerulosclerosis, in which proteinuria is often non-proteins, including the physiologic reabsorption of LMW
proteins, is increasingly impaired, leading to the urinary selective. However, more recently, Mallick, Short and
Manos [130] showed that, even in membranous nephrop-excretion of a progressively larger fraction of LMW pro-
teins (Fig. 2 C and D). It has been found that such athy, the selectivity index could discriminate between
patients who remitted and those whose proteinuria per-impairment of the reabsorption of LMW proteins, in
glomerular diseases with severe and/or protracted pro- sisted, the former having a SI lower than 0.19 (Table 1).
Woo et al [131] confirmed the predictive value of SI inteinuria, correlates with the extent of the injury of the
tubular cells and with the overall tubulointerstitial dam- 98 patients with IgA nephropathy (Table 2). We [132]
calculated the SI in 89 patients with nephrotic syndromeage [104–109]. Accumulating evidence suggests that
direct toxicity for the tubular cells of some as yet non- due to membranous nephropahy, focal segmental glomer-
ulosclerosis or minimal-change nephropathy, but classi-identified proteins reaching the tubular lumen might be
responsible for the injury of such cells, triggering the fied patients in three subgroups instead of two. Since as
many as 59% of membraneous nephropathy patients andrelease of a number of proinflammatory cytokines and
growth factors, which cause an inflammatory and fibrotic 38% of focal segmental glomerulosclerosis patients had
a SI lower than the cut-off value of 0.2 but higher than 0.1,response in the interstitium [108–124].
we classified proteinuria as highly selective (SI 	0.10),
moderately selective (SI 
 0.11 	 0.20), or nonselective
QUANTITY AND QUALITY OF PROTEINURIA
(SI
0.21). Although the total amount of proteinuria was
PREDICT THE CLINICAL COURSE AND
comparable in the three groups, a significant difference in
THE RESPONSE TO THERAPY IN
clinical remission, in progression to chronic renal failure
GLOMERULAR DISEASES
and in response to therapy was found (Tables 1 and 2).
Predictive value of amount of proteinuria and of A correlation between the SI and the semiquantitative
tubulointerstitial lesions evaluation of histologic lesions showed that the extent
of tubulointerstitial damage in patients with highly orData accumulated in the last decade have demonstrated
that in all glomerular diseases the amount of proteinuria, moderately selective proteinuria was significantly less
severe than in those with nonselective proteinuria, whiletogether with the degree of the tubulointerstitial damage,
is the most powerful predictor of the progression to global glomerular sclerosis did not show a significant
relationship with SI (Table 3). Bakoush et al [133] havechronic renal failure [107, 109, 110, 125–129].
The analysis of the pathophysiologic mechanisms of very recently confirmed in a group of 56 proteinuric
patients with various glomerular diseases that the IgG/proteinuria performed in the preceding section gives a
good theoretical explanation of the value of these two transferrin SI below or above 0.2 is significantly corre-
lated with the severity of histologic lesions (Table 3).parameters as prognostic indicators. The extent of pro-
teinuria is an indicator of the severity of the alterations The same group of investigators [26] has proposed a
different measure of SI, based on the comparison of theof the glomerular capillary wall and of its permeability,
and, therefore, can be a good marker of the overall sever- clearance of IgM (instead of IgG) to that of albumin (in-
stead of transferrin), on the assumption that the higherity of the glomerular damage. The consequent involve-
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Table 1. Predictive value of some qualitative markers of proteinuria for clinical remission in primary chronic glomerulonephritides
Glomerular No. of Predictive value for
Reference (No.) diseases patients Markers of proteinuria tested clinical remission
Mallick et al, 1983 (130) MN 40 IgG/transferrin selectivity index ( vs. 
0.19) Yes
Bazzi et al, 2000 (132) MCN, MN, FSGS 60 IgG/transferrin selectivity index (	0.10; 
0.11 	 0.20; 
0.21) Yes
Proteinuria (g/24 hours) No
Bazzi et al, 2001 (135) MN 38 IgG excretion (mg/g urine creatinine) Yes
1-microglobulin excretion (mg/g urine creatinine) Yes
Proteinuria (g/24 hours) No
Bazzi et al, 2002 (136) FSGS 29 Fractional excretion of IgG Yes
Fractional excretion of 1-microglobulin Yes
Proteinuria (g/24 hours) No
Abbreviations are: MN, membraneous nephropathy; MCN, minimal-change nephropathy; FSGS, focal segmental glomerulosclerosis.
Table 2. Predictive value of some qualitative markers of proteinuria for progression to chronic renal failure in
primary chronic glomerulonephritides
Predictive value for
No. of progression to
Reference (No.) Glomerular diseases patients Markers of proteinuria tested chronic renal failure
Bazzi et al, 2000 (132) MCN, MN, FSGS 60 Selectivity index (IgG/transferrin) Yes
(	0.10; 
0.11 	 0.20; 
0.21)
Proteinuria (g/24 hours) No
Bakoush et al, 2001 (26) MCN, MN, IgA nephropathy 84 Selectivity index (IgM/albumin) Yes
Albuminuria (albumin/creatinine index) Yes
Woo et al, 1989 (131) IgA nephropathy 98 Selectivity index (IgG/transferrin) (0.20; 0.20) Yes
Woo et al, 1991 (138) 60 LMW proteins at SDS-PAGE Yes
Bazzi et al, 1997 (139) MN, MPGN, FSGS 82 LMW proteins 20 kD at SDS-PAGE Yes
Reichert et al, 1997 (134) MN 22 IgG excretion (mg/day) Yes
Proteinuria (g/24 hours) No
Reichert et al, 1995 (140) MN 30 2-microglobulin excretion (mg/day) Yes
Proteinuria (g/24 hours) No
Bazzi et al, 2001 (135) MN 38 IgG excretion (mg/g urine creatinine) Yes
1-microglobulin excretion (mg/urine creatinine) Yes
Proteinuria (g/24 hours) No
Bazzi et al, 2002 (136) FSGS 29 Fractional excretion of IgG Yes
Fractional excretion of 1-microglobulin Yes
Proteinuria (g/24 hours) Yes
Abbreviations are: MN, membranous nephropathy; MCN, minimal-change nephropathy; MPGN, membranoproliferative glomerulonephritis; FSGS, focal segmental
glomerulosclerosis; LMW, low-molecular-weight; SDS-PAGE, sodium dodecyl sulphate-polyacrylamide gel electrophoresis.
Table 3. Correlations between some qualitative markers of proteinuria and severity of histological damage in
primary chronic glomerulonephritides
Tubular
Glomerular No. of Glomerular interstitial Vascular
Reference, year (No.) diseases patients Markers of proteinuria tested damage damage damage
Bazzi et al, 2000 (132) MCN, MN, FSGS 61 IgG/tranferrin selectivity index No Yes No
(	0.10; 
0.11 	 0.20; 
0.21)
Bakoush et al, 2001 (133) MCN, MN, FSGS 56 IgG/tranferrin selectivity index No Yes —
(	0.20 vs. 0.20)
Bakoush et al, 2001 (26) MN, IgA nephropathy 84 IgM/albumin selectivity index Yes Yes —
(	0.002 vs. 0.002) (Global sclerosis)
Albuminuria (albumin/creatinine index) No No —
Nagy et al, 1987 (137) IgA nephropathy 45 LMW proteinuria at SDS-PAGE — Yes —
Woo et al, 1991 (138) IgA nephropathy 60 LMW proteinuria at SDS-PAGE — Yes —
Bazzi et al, 1997 (139) MN, MPGN, FSGS 80 LMW proteins 20kD at SDS-PAGE No Yes Yes
Bazzi et al, 2001 (135) MN 48 IgG excretion (mg/g urine creatinine) No Yes No
1-microglobulin excretion Yes Yes Yes
(mg/g urine creatinine)
Proteinuria (g/24 hrs) No No No
Bazzi et al, 2002 (136) FSGS 30 Fractional excretion of IgG Yes (% segmental sclerosis) No —
Fractional excretion of 1-microglobulin No Yes —
Abbreviations are: MN, membranous nephropathy; MCN, minimal-change nephropathy; MPGN, membranoproliferative glomerulonephritis; FSGS, focal segmental
glomerulosclerosis; LMW, low-molecular weight; SDS-PAGE, sodium dodecyl sulphate-polyacrylamide gel electrophorosis.
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molecular weight of IgM in comparison with IgG could the rate of remission or progression to chronic renal
failure between treated and untreated patients when thereveal a more severe disruption of the permeability of
the glomerular capillary wall. Dividing 67 patients with baseline values of IgG were less than the cut-off value.
When IgG excretion values were greater than the cut-various primary glomerular diseases (IgA nephropathy,
membraneous nephropathy and mesangial proliferative off value, however, a difference between treated and
untreated patients for progression to chronic renal fail-glomerulonephritis) into two subgroups, respectively,
with low (	0.002) and high (0.002) SI based upon IgM ure at the limit of statistical significance (10% vs. 60%;
P  0.05) was found.(IgM-SI), they found that at the end of the follow-up
significantly less patients with low IgM-SI had a decline We have concluded a similar study in 50 patients with
primary focal segmental glomerulosclerosis (FSGS) [136]of creatinine clearance, despite the fact that the initial
average amount of proteinuria was higher in patients with and in 30 patients with membranoproliferative glomerulo-
nephritis (unpublished observations), with very similarlow IgM-SI (Table 2). In patients with low IgM-SI, the
number of obsolescent glomeruli was significantly lower results (Table 1 to 3). In 29 FSGS patients with nephrotic
syndrome and baseline normal renal function the frac-and the extent of interstitial fibrosis significantly less
marked (Table 3). No significant difference could be tional excretion of IgG, below or above a defined cutoff,
predicted remission in 91% and progression to end-stagefound when the same parameters were correlated with
albuminuria. At the multiple regression analysis, IgM-SI, renal failure in 71% of patients, respectively. Further-
more, a significant difference (P  0.000) was observedbut not albumin excretion rate, appeared to be significant
predictor of decline of renal function (Table 2). for therapy responsiveness according to fractional excre-
tion of IgG: 70% of patients with fractional excretion ofSince the discriminant factor, in the evaluation of the
SI, is the urinary excretion of proteins with the highest IgG 0.025 were responsive to steroids alone, 80% of
patients with fractional excretion of IgG
0.025 to0.140molecular weight, the urinary excretion of IgG has been
used as a marker of severity of the glomerular damage by were responsive to steroids and cyclophosphamide in com-
bination, 100% of patients with fractional excretion ofsome investigators. Reichert, Koene, and Wetzels [134]
evaluated the predictive value for progression of urinary IgG 0.140 were unresponsive to both drugs [136].
In our three cohorts of nephrotic patients (membranousexcretion of IgG, together with total proteins, albumin,
and transferrin, in 22 patients with membraneous ne- nephropathy, focal segmental glomerulosclerosis, and
membranoproliferative glomerulonephritis), we have mea-phropathy, nephrotic syndrome, and normal renal func-
tion. Only excretion of IgG and transferrin, but not that sured the urinary excretion of another HMW protein,
2-macroglobulin, of molecular radius 90 A˚, the con-of total proteins, was significantly different in progressors
versus nonprogressors. By multivariate analysis, only centration of which is usually extremely low, below the
detectability limits, even in many pathologic conditionsIgG excretion was independently associated with deteri-
oration of renal function (Table 2). characterized by increased size permeability of the glo-
merular barrier. This very large protein was detectableWe studied the predictive value of the excretion of
IgG, expressed in milligrams per gram of urinary creati- in the urines in the totality (focal segmental glomerulo-
sclerosis and membranoproliferative glomerulonephritis)nine and logaritmically transformed, in 78 patients with
biopsy-proved membraneous nephropathy [135]. The ex- or great majority (79%, in membranous nephropathy) of
patients in whom the IgG fractional excretion was abovecretion of IgG, but not albumin, transferrin, or 24-hour
proteinuria, significantly correlated with the severity of the cut-off levels selected for each of the three diseases,
while it was undetectable in the majority of patients whosethe tubulointerstitial damage, while no correlation was
found between glomerulosclerosis and any of the pro- fractional excretion of IgG, even though markedly in-
creased, was below the cut-off levels. These findings sug-teinuric parameters, including IgG excretion (Table 3).
In one half of the patients, who had a nephrotic syndrome gest that the large pores permitting the transglomerular
passage of HMW proteins in nephrotic patients discrimi-and a normal renal function at the time of the evaluation
of proteinuria and renal biopsy, and a sufficiently long nate between IgG (55 A˚) and 2-macroglobulin (90 A˚),
as they discriminate, according to Bakoush et al [26],follow-up, complete or partial remission was significantly
different (100% vs. 20%) according to a urinary excre- between IgG and IgM (120 A˚). They can be explained
assuming that discriminatory large pores exist, the den-tion of IgG lower or higher of a cut-off level of 110 mg/g
urinary creatinine (Table 1), as was progression to chronic sity of which declines with their size.
renal failure (0% vs. 35%); on the contrary, an amount
Predictive value of fractional excretion of proteins ofof 24-hour proteinuria below or above 5 g did not show
very LMW (“tubular” proteins)any discriminant value for either remission or progres-
sion (Tables 1 and 2). In the same study [135], 19 patients In 1987, Nagy et al [137] studied the proteinuria in
45 patients with IgA nephropathy and found that thetreated with immunosuppressive therapy were compared
with 19 untreated patients. There was no difference in presence of LMW proteins in the sodium dodecyl sulfate-
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polyacrylamide gel electrophoresis (SDS-PAGE) pro- nine) progressed more frequently to chronic renal failure
(Table 2) and had a lower rate of clinical remission (Ta-teinuric pattern was significantly associated with higher
values of serum creatinine and was correlated with tu- ble 1). As reported above, in the same population of
patients urinary excretion of IgG was also significantlybulointerstitial lesions (Table 3). In 1991, Woo et al
[138] characterized proteinuria with SDS-PAGE in 60 correlated with remission and progression to chronic re-
nal failure, while an amount of 24-hour proteinuria belowpatients with the same disease and found that the pres-
ence of LMW proteins was significantly associated with or above 5 g did not show any discriminant value either
for remission or for progression. By multiple logistic re-a higher incidence of chronic renal failure after 6 years
of follow-up (Table 2); the proteinuric patterns were also gression analysis 1-microglobulin, but not IgG or 24-hour
proteinuria, was significantly associated with progressioncorrelated with tubular atrophy and tubulointerstitial le-
sions (Table 3). We [139] measured LMW proteins by to chronic renal failure. Only in patients with 1-micro-
globulin excretion above the cut-off level, a significant dif-SDS-PAGE in 145 patients with proteinuric primary
glomerulonephritis (focal segmental glomerulosclerois, ference in the rate of progression to chronic renal failure
was found between treated (steroids and immunosup-membranous nephropathy, and membranoproliferative
glomerulonephritis), further distinguishing the molecular pressors) and untreated patients (17% vs. 100%). A simi-
lar study in 50 patients with primary focal segmentalweight according to the presence or absence of LMW pro-
teins of a molecular weight below 20 kD (as low as 10 kD). glomerulosclerosis [136] and in 30 patients with idio-
pathic membranoproliferative glomerulonephritis (un-We found that the presence of such proteins of very
LMW was significantly associated with a higher serum published data) gave comparable results (Tables 1 to 3).
creatinine level, more marked proteinuria, and more se-
vere tubulointerstitial damage (Table 3). The presence
CONCLUSION
at baseline of LMW 20 kD significantly predicted the
Two major mechanisms are responsable for the abnor-progression to chronic renal failure (Table 2). In the 20
mal urinary excretion of proteins that characterizes allpatients of this cohort who were treated with steroids
glomerular diseases, with or without nephrotic syndrome.(alone or in combination with cyclophosphamide), re-
The first is an increased charge and size permeability ofsponse to therapy was significantly lower in those with
the glomerular capillary wall, leading to the transglomer-presence of LMW proteins 20 kD (30% vs. 80%).
ular passage of albumin and of proteins of HMW thatReichert, Koene, and Wetzels [140] and our group [135–
usually do not cross the glomerular barrier. The second136] confirmed the value of LMW proteins as sensitive
is the consequent impairment of the mechanism of reab-markers of proximal tubular function, and therefore of
sorption of all proteins and, in particular, of the LMWtubulointerstitial damage and progressive disease, mea-
proteins by the epithelial cells of the proximal tubule,suring directly the urinary excretion of single proteins
due to increased work and/or toxic injury deriving fromof this class. Reichert, Koene, and Wetzels [140] mea-
the increased load of the abnormally filtered proteins insured the urinary excretion of 2-microglobulin in 30
the tubular lumen.patients with membranous nephropathy, nephrotic syn-
The quantity and the molecular weight and radius ofdrome, and normal renal function and found that pro-
the proteins that reach the tubular lumen increase progres-gression to chronic renal failure was significantly more
sively with the increasing severity of the disruption offrequent when its excretion was greater than 500 ng/min
the structural integrity of the glomerular capillary walls,(Table 2). In 48 patients with membranous nephropathy,
with the consequent impairment of the selectivity of thewe [135] found that the excretion of 1-microglobulin
“barrier” to the transglomerular passage of proteins. Inwas significantly associated with the extent of tubulo-
the less severe cases with selective proteinuria, albumininterstitial damage, global glomerular sclerosis, and
(molecular weight  69 kD; molecular radius  36 A˚)arteriolar hyalinosis (Table 3). By contrast, no correla-
is the prevalent abnormal protein (Fig. 2B). With thetion was found between 24-hour total urinary protein
escalating severity of the glomerular lesions, increasingexcretion, albumin, or transferrin, and any of the histo-
amounts of proteins of larger molecular weight crosslogic features. By multiple regression analysis, in a larger
the glomerular capillary wall, and the amount of IgGpopulation of 78 patients with membranous nephropa-
(molecular weight  150 kD; molecular radius 55 A˚)thy, we found a significant correlation between urinary
in the tubular lumen increases progressively (Fig. 2C).1-microglobulin excretion and that of IgG, but not of
In the most severe cases, even proteins like 2-macro-albumin or total urinary protein excretion [135]. A
globulin (molecular weight 720 kD; molecular radiusseparate analysis, in the subgroup of patients who had
90 A˚) and IgM (molecular weight  900 kD; molecularnephrotic syndrome and normal renal function at the
radius  120 A˚) reach the tubular lumen (Fig. 2D). It is,time of evaluation of proteinuria, revealed that those
therefore, theoretically correct that the SI of proteinuriawith a very high urinary excretion of 1-microglobulin
(higher than a cut-off level of 33.5 mg/g urinary creati- based on IgM excretion, or the fractional urinary excre-
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tion of IgG, may be a better marker of the severity of HMW and LMW proteins. However, the concomitant
measurement of both these urinary markers is clinicallythe damage of the glomerular capillary wall than the
overall amount of proteinuria. The clinical studies re- justified in our opinion, since IgG is more related to the
glomerular damage, and 1-microglobulin to the tubulo-ported above, and summarized in the Tables 1 to 3,
confirm this assumption. interstitial damage. This damage is consequent but not
necessarily strictly correlated with the ongoing glomeru-In all the primary glomerular diseases with prevalent
damage of the glomerular capillary walls and proteinuria lar injury. The fact, reported above, that the fractional
excretion of IgG is a better predictor of clinical remissionin the nephrotic range (membranous nephropathy, focal
segmental glomerulosclerosis, and membranoprolifera- than fractional excretion of 1-microglobulin in patients
with membranous nephropathy, while the latter bettertive glomerulonephritis), urinary excretion of IgG or
IgM, but not 24-hour proteinuria, predicted both clinical predicts the progression to chronic renal failure than the
former, appear to confirm that the predictive role ofremission and progression to chronic renal failure and
was correlated with the histologic lesions, especially tu- these two parameters can be different. However, at the
regression analysis in membranous nephropathy and fo-bulointerstitial damage.
The increased transit in the tubular lumen of large cal segmental glomerulosclerosis, their contemporary
evaluation did not show any additional value for pre-amounts of proteins of HMW induces a progressively
increasing damage of the epitelial cells of the proximal dicting the clinical outcome in comparison with each of
them considered separately (unpublished data). We stilltubule and the activation of the network of cytokines
and growth factors that induces interstitial infiltration measure the fractional excretion of both these markers
as a routine in all proteinuric glomerular diseases, andand fibrosis, primarily responsible for the progressive
deterioration of renal function. It is, therefore, theoreti- recommend doing so in the clinical practice, especially
when no morphologic data from biopsy are available.cally justified that the presence of great fractions of pro-
teins of very LMW, which escaped tubular reabsorption, The impact of the baseline fractional excretion of IgG
(but not of the 24-hour proteinuria) on the therapeuticsuch as 1-microglobulin (molecular weight  31 kD) or
2-microglobulin (molecular weight  11.8 kD), in the response to a prolonged cycle of steroids, given alone
or in association with cyclophosphamide in our patientsurine may be a more reliable marker of the severity of
the tubulointerstitial damage than the overall amount with focal segmental glomerulosclerosis, deserves some
commentary. Only when the fractional excretion of thisof proteinuria. The clinical studies reported above, and
summarized in the Tables 1 to 3, confirm even this as- marker of HMW proteins was below a defined cut-off
limit, was a total or partial response obtained in thesumption.
Considering the great number of factors that intervene majority of patients. A possible explanation of these
results is that therapy is efficacious only when the densityduring the course of chronic glomerular diseases and
that may affect the evolution of the damage and the of largest pores (of which the fractional excretion of
IgG is a good marker) is in the normal range or onlynatural history, it is surprising to find that the amount
of HMW and LMW proteins detected in the urine at the moderately increased. As observed by Ikegaya et al [61],
steroids and immunosuppressors may correct the sizebeginning of the observation period is a rather accurate
predictive marker of the subsequent outcome. This find- barrier defect, only within a limited range of disruption
of the integrity of the glomerular capillary wall.ing suggests that there is a point of irreversibility of the
anatomic damage, both at the level of the glomerular
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